Results for tag: "Fiasp"

Fiasp is a class of diabetes drugs used to treat type 1 and type 2 diabetes. It is a fast-acting insulin analog that is taken at mealtime to help control blood sugar levels. Fiasp is designed to be taken shortly before or after a meal, and it works quickly to reduce post-meal blood sugar levels. It is also designed to provide a more consistent level of insulin throughout the day. Fiasp is typically used in combination with other diabetes medications, such as long-acting insulin, to help manage blood sugar levels. Fiasp is available in both injectable and inhalable forms. The injectable form is typically taken once or twice a day, while the inhalable form is taken just before meals. Fiasp is generally well-tolerated and has few side effects. The Fiasp market is highly competitive, with several companies offering their own versions of the drug. These companies include Novo Nordisk, Sanofi, Eli Lilly, and Merck. Each company offers its own unique formulation of Fiasp, with different dosing schedules and delivery methods. Show Less Read more